Is Thrombolysis Useful for Acute Stroke Patients? The Experience of the MAST-I Study
Experimental and physiopathological studies suggest that reperfusion may be useful to prevent the extension of brain infarction if performed in a reasonable period of time after ischemic insult. Thrombolytic agents recanalize myocardial and cerebral vessels, but it is not yet known if they are able to reperfuse brain ischemic tissue. There is some experimental evidence in animals of their efficacy, but it is still uncertain if these agents are able to reduce the size of brain infarct and improve clinical outcome in man.
KeywordsAcute Stroke Acute Ischemic Stroke Thrombolytic Therapy Thrombolytic Agent Recombinant Tissue Plasminogen Activator
Unable to display preview. Download preview PDF.
- 1.The MAST-I Collaborative Group (1993) Thrombolytic and antithrombotic therapy in acute ischemic stroke. Multicenter Acute Stroke Trial—Italy (MAST-I) In: del Zoppo GJ. Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin, pp 86–94Google Scholar
- 2.Flechter AP, Alkjaersig N, Smyrniotis FE, Sherry S (1958) The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians 71: 287–296Google Scholar
- 3.Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (1990) GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 336: 65–71Google Scholar
- 5.ISIS-3 (Third International Study of Infarct Survival) Collaborative Group (1992) ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 339: 753–70CrossRefGoogle Scholar
- 8.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349–360Google Scholar
- 10.del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86PubMedCrossRefGoogle Scholar